ArticleBiotechnology reports (Amsterdam, Netherlands)2023

Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model.

Balamurugan Shanmugaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.